封面
市场调查报告书
商品编码
1548167

全球辅助生殖技术市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Assisted Reproductive Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球辅助生殖技术市场需求预计将从2023年的330.5亿美元达到近587亿美元的市场规模,2024-2032年研究期间复合年增长率为6.59%。

辅助生殖技术 (ART) 是指一系列用于解决不孕症和帮助个人怀孕的医疗程序。 ART 包括体外受精 (IVF)、胞浆内单一精子注射 (ICSI) 以及配子或胚胎冷冻保存等技术。这些方法涉及在体外操纵卵子、精子和胚胎,以提高怀孕的机会。 ART 用于传统受孕方法因精子数量低、输卵管阻塞或与年龄相关的生育问题等因素而失败的情况。 ART 领域取得了重大进展,提高了成功率,并为患有不孕症的个人和夫妻提供了新的选择。

市场动态

生活方式的改变、生育延迟和生殖疾病盛行率上升导致不孕率上升,推动了辅助生殖技术市场的发展。例如,美国生殖医学会强调,全球约有 10-15% 的夫妇患有不孕症。技术进步,例如体外受精技术的改进和基因筛检工具的开发,为提高成功率和个人化治疗提供了新的机会。此外,不同族群对 ART 治疗的认识和接受程度不断提高,也导致需求不断增长。旨在支持不孕症治疗和研究的政府措施和资金进一步促进辅助生殖技术市场的成长。这些驱动因素和机会共同增强了市场发展和创新的潜力。然而,高昂的治疗成本和伦理问题可能会限制辅助生殖技术市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球辅助生殖技术市场的各个细分市场进行了包容性评估。辅助生殖技术产业的成长和趋势为本研究提供了整体方法。

市场区隔

辅助生殖技术市场报告的这一部分提供了国家和区域层面细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 体外受精 (IVF)(新鲜供体、冷冻供体、新鲜非供体、冷冻非供体)
  • 人工授精(子宫内授精、子宫颈内授精、阴道内授精、输卵管内授精)
  • 最终用途
  • 生育诊所及其他设施
  • 医院及其他

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲辅助生殖技术市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。辅助生殖技术市场的主要参与者包括 Cosmos Biomedical、Microm UK Ltd.、Origio (CooperSurgical)、Irvine Scientific、Cryolab Ltd.、Parallabs、欧洲精子库、Bloom IVF 中心。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:辅助生殖技术 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球辅助生殖技术市场分析:按类型

  • 按类型概述
  • 按类型分析历史和预测数据
  • 体外受精 (IVF)(新鲜供体、冷冻供体、新鲜非供体、冷冻非供体)
  • 人工授精(子宫内授精、子宫颈内授精、阴道内授精、输卵管内授精)
  • 最终用途
  • 生育诊所及其他设施
  • 医院及其他

第 6 章:全球辅助生殖技术市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 7 章:辅助生殖科技公司的竞争格局

  • 辅助生殖技术市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 8 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Cosmos Biomedical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Microm UK Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Origio (CooperSurgical)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Irvine Scientific
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cryolab Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Parallabs
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • European Sperm Bank
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bloom IVF Centre
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资料和最新进展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR112115483

The global demand for Assisted Reproductive Technology Market is presumed to reach the market size of nearly USD 58.7 Billion by 2032 from USD 33.05 Billion in 2023 with a CAGR of 6.59% under the study period 2024-2032.

Assisted reproductive technology (ART) refers to a range of medical procedures used to address infertility and assist individuals in conceiving a child. ART encompasses techniques such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete or embryo cryopreservation. These methods involve manipulating eggs, sperm, and embryos outside the body to enhance the chances of pregnancy. ART is employed in cases where traditional conception methods are unsuccessful due to factors like low sperm count, blocked fallopian tubes, or age-related fertility issues. The field of ART has seen significant advancements, improving success rates and providing new options for individuals and couples struggling with infertility.

MARKET DYNAMICS

The assisted reproductive technology market is driven by increasing infertility rates, attributed to lifestyle changes, delayed childbearing, and rising prevalence of reproductive disorders. For instance, the American Society for Reproductive Medicine highlights that infertility affects approximately 10-15% of couples globally. Technological advancements, such as improved IVF techniques and the development of genetic screening tools, offer new opportunities for enhancing success rates and personalizing treatment. Moreover, rising awareness and acceptance of ART treatments across diverse populations contribute to growing demand. Government initiatives and funding aimed at supporting infertility treatments and research further bolster assisted reproductive technology market growth. These drivers and opportunities collectively enhance the potential for market development and innovation. However, high treatment costs and ethical concerns may restrain assisted reproductive technology market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Assisted Reproductive Technology. The growth and trends of Assisted Reproductive Technology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Assisted Reproductive Technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor)
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination)
  • End-Use
  • Fertility Clinics & Other Facilities
  • Hospitals & Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Assisted Reproductive Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Assisted Reproductive Technology market include Cosmos Biomedical, Microm U.K. Ltd., Origio (CooperSurgical), Irvine Scientific, Cryolab Ltd., Parallabs, European Sperm Bank, Bloom IVF Centre. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ASSISTED REPRODUCTIVE TECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor) Historic and Forecast Sales By Regions
  • 5.4. Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination) Historic and Forecast Sales By Regions
  • 5.5. End-Use Historic and Forecast Sales By Regions
  • 5.6. Fertility Clinics & Other Facilities Historic and Forecast Sales By Regions
  • 5.7. Hospitals & Others Historic and Forecast Sales By Regions

6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE ASSISTED REPRODUCTIVE TECHNOLOGY COMPANIES

  • 7.1. Assisted Reproductive Technology Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF ASSISTED REPRODUCTIVE TECHNOLOGY INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Cosmos Biomedical
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Microm U.K. Ltd.
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. Origio (CooperSurgical)
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. Irvine Scientific
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Cryolab Ltd.
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. Parallabs
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. European Sperm Bank
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments
  • 8.10. Bloom IVF Centre
    • 8.10.1 Company Overview
    • 8.10.2 Company Revenue
    • 8.10.3 Products
    • 8.10.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor) Market Sales By Geography (USD MN)
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination) Market Sales By Geography (USD MN)
  • End-Use Market Sales By Geography (USD MN)
  • Fertility Clinics & Other Facilities Market Sales By Geography (USD MN)
  • Hospitals & Others Market Sales By Geography (USD MN)
  • Global Assisted Reproductive Technology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Assisted Reproductive Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Assisted Reproductive Technology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor) Market Sales By Geography (USD MN)
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination) Market Sales By Geography (USD MN)
  • End-Use Market Sales By Geography (USD MN)
  • Fertility Clinics & Other Facilities Market Sales By Geography (USD MN)
  • Hospitals & Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.